Fundraising FoxHealthtech Startups
18,778 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
Seniorly operates an online directory of senior living communities and connects families with local advisors and virtual tools to find assisted living, memory care, and independent living options. It provides free advisory services, cost calculators, care quizzes, and guides for families in the United States.
0 investors
0 investors
0 investors
0 investors
Sensei operates wellness retreats in secluded destinations, offering personalized packages and curated programs guided by wellness practitioners. Its programs focus on preventative health across three areas: movement, nutrition, and rest.
0 investors
InnerVision Design Group (IDG) is a creative image and marketing solutions company that produces marketing tools across print, web, video, audio, promotional, and live-event formats. It serves clients seeking brand awareness and marketing content, acting as an outsourced marketing and media creation team.
0 investors
0 investors
0 investors
Sensus Healthcare develops Superficial Radiotherapy (SRT) medical devices, including the SRT-100, SRT-100+ and SRT-100 Vision (which adds high-frequency ultrasound imaging), used to treat non-melanoma skin cancer and keloids without surgery. The devices are sold to physicians, institutions and healthcare systems for non-invasive, in-office outpatient treatment.
0 investors
Senté develops medical-grade skincare products built around its patented HSA (heparan sulfate analog) repair molecule, designed to reduce redness, even skin tone, and support the skin barrier for all skin types including sensitive skin. The dermatologist-recommended, clinically tested formulas are sold direct to consumers through kits, sets, and a personalized skincare quiz.
0 investors
Sentiré Medical Systems develops gas sensing technology for minimally invasive surgery that provides surgeons with additional intraoperative information. The SENSai platform integrates chemical sensing capabilities into operating room workflows to enhance surgical awareness and efficiency.
0 investors
0 investors
0 investors
Sepragen develops chromatography and bioreactor systems for large-scale pharmaceutical and biopharmaceutical manufacturing, including vaccine production, monoclonal antibodies, and viral vectors. The company serves pharmaceutical manufacturers and contract manufacturers requiring purification and bioprocessing equipment at production scale.
0 investors
Septal Solutions develops minimally invasive transcatheter devices for treating structural heart disease, aimed at improving patient outcomes through simplified, precise interventions.
0 investors
Sequella is a clinical-stage pharmaceutical company developing antibiotics to treat drug-resistant bacterial, fungal, and parasitic infections, including tuberculosis, MDR-TB, XDR-TB, H. pylori, and C. difficile. Its pipeline includes drug candidates such as SQ109 and sutezolid, which have completed phase 2 clinical trials.
0 investors
Sequoia Sciences is a biotechnology company developing vaccines, including a vaccine to prevent recurrent urinary tract infections, with programs spanning clinical development, regulatory strategy, and manufacturing. The company works on immune therapies for infectious diseases and cancer.
0 investors
Serenity Medical is a medical device company developing the River Stent, an investigational device for treating debilitating venous diseases such as Idiopathic Intracranial Hypertension (IIH) and Pulsatile Tinnitus, conditions that disproportionately affect women.
0 investors
Seriously Clean Ltd. is a contract manufacturer of Hypochlorous Acid (HOCl) products, including FDA-cleared 510(k) medical devices for wound management (prescription and over-the-counter), cosmetics, and an EPA-registered hospital-grade disinfectant with a C. difficile kill claim. It produces products for other companies across cosmetics, medical device distribution, eye care, animal, and skin care markets.
0 investors
Sermonix Pharmaceuticals is a privately held biotechnology company developing female-specific oncology products, with a lead investigational drug, lasofoxifene, being studied for breast and ovarian cancer. Its ELAINE study evaluates lasofoxifene versus fulvestrant in women with ER+/HER2- metastatic breast cancer carrying an ESR1 mutation.
0 investors